IP Verse

Acceleron Pharma competitive analysis

Loading summary...

Latest patents of Acceleron Pharma opposed by its competitors

Explore Acceleron Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 6, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3490582
Jun 12, 2024Methods And Compositions For Treating Myelofibrosis2
EP3226887
Mar 27, 2024Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias1
EP3380121
Dec 20, 2023Methods For Treating Eye Disorders1

Latest PTAB cases involving Acceleron Pharma

Discover the latest PTAB cases involving Acceleron Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Acceleron Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACCELERON PHARMA - 4 - -
MAIWALD136 - - -
WUESTHOFF & WUESTHOFF14 - - -
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB33 - - -